Explore 3 Stock Ideas & Industry Insights Download Free Report

888-969-2592
Shopping Cart 0
countryflagCA
Login

Home CompaniesRapid Dose Therapeutics Corp

Rapid Dose Therapeutics Corp

Healthcare Biotechnology
PortfolioPortfolio WatchlistWatchlist
Company price
0.105 CAD 0.01 ( 16.67%)
Last update at 2026-11-04T14:30:00Z
VOLUME
2000
Market Cap
14.16M

Momentum Score

…

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips that consists of active ingredients. In addition, the company sells health and wellness products, such as nutraceuticals and infused soaps; and white label manufacturing, including oral thin film strips containing active ingredients under cannabis licensing, as well as provides consulting services for the application of active ingredients. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.

Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website

Day Price Range
0.10
Low
0.10
High
52 Week Price Range
0.09
Low
0.24
High

Momentum Score

…
Loading momentum score…

A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.

Score - Rating
>= 1 - Low / > 1 but < 2 - Below Average / > 2 but < 3 - Average / > 3 but < 4 - Above Average / > 4 - High
AI Summary

Rapid Dose Therapeutics develops and commercializes fast-dissolving oral thin-film delivery technologies for pharmaceutical and cannabinoid products. Long-term growth may be driven by adoption of non-inhalation cannabinoid delivery, licensing of its platform to pharmaceutical and consumer brands, and expansion in regulated cannabis markets, which could support revenue diversification and technology licensing.
Primary risks include regulatory uncertainty in cannabis and pharmaceutical markets, competition from alternative delivery formats, limited commercial scale and the financing and execution risk typical of small-cap specialty therapeutics companies.

Risk Score
High

Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.

Key Metrics*

Previous Close
0.09
Dividend Yield
-
Revenue TTM
2.78M
Revenue Per Share
0.02
Gross Profit TTM
1.40M
Debt / Equity
-
ROE
-188.85%
Net Debt
2.59M
ROCE
80.14%
Diluted EPS TTM
-0.02

Key Financials*

Income Statement

Balance Sheet

Change in Cash

Total Operating Cash

Dividends Paid

Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Income before tax -5.40M -4.31M -3.81M -8.49M -2.30M
Net income -5.40M -4.31M -3.81M -8.49M -2.30M
Selling general administrative 4.96M 2.61M 3.18M 4.39M 1.50M
Gross profit 1.18M 0.56M 0.37M 1.34M 0.21M
Reconciled depreciation 0.24M 0.62M 0.63M 0.77M 0.68M
Ebit - - -3.54M -4.30M -1.63M
Ebitda - - - - -1.48M
Operating income -4.17M -3.09M -3.54M -4.30M -2.13M
Interest expense 1.23M 0.66M 0.26M 0.13M 0.14M
Interest income - - 0.00M 0.00M 0.00M
Net interest income -1.23M -0.66M -0.26M -0.13M -0.14M
Total revenue 2.09M 1.02M 0.72M 1.75M 0.26M
Total operating expenses 6.26M 4.11M 4.26M 6.05M 2.39M
Cost of revenue 0.91M 0.46M 0.35M 0.41M 0.06M
Total other income expense net - -0.56M -0.00M -4.05M -0.03M
Net income from continuing ops -5.40M -4.31M -3.81M -8.49M -2.30M
Net income applicable to common shares - - -3.81M -8.49M -1.81M
Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Total assets 1.63M 1.89M 2.25M 3.07M 3.83M
Total liab 6.84M 5.04M 4.92M 2.82M 5.41M
Total stockholder equity -5.21M -3.16M -2.67M 0.25M -1.58M
Other current liab - - 0.53M 0.02M 0.90M
Common stock - - 25.13M 25.00M 18.60M
Capital stock 28.26M 26.61M 25.13M 25.00M 18.60M
Retained earnings -44.60M -39.26M -34.97M -31.16M -22.67M
Cash 0.02M 0.16M 0.03M 0.03M 0.07M
Total current liabilities 6.84M 2.92M 4.70M 2.45M 4.25M
Net debt 2.59M 2.06M 1.22M 0.47M 1.03M
Short long term debt 2.61M 0.09M 1.06M 0.50M 1.10M
Other stockholder equity - - 2.32M 2.26M 0.34M
Property plant equipment - - 1.83M 2.45M 3.03M
Total current assets 0.66M 0.68M 0.42M 0.61M 0.80M
Net tangible assets - - -2.67M 0.25M -1.09M
Net receivables 0.14M 0.03M 0.06M 0.07M 0.08M
Long term debt - 2.12M 0.19M - -
Inventory 0.25M 0.13M 0.15M 0.28M 0.37M
Accounts payable 1.94M 1.12M 2.78M 1.36M 1.83M
Non current assets total 0.97M 1.21M 1.83M 2.45M 3.03M
Capital lease obligations 0.00M 0.03M 0.36M 0.67M 0.96M
Breakdown 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Type yearly yearly yearly yearly yearly
Date 2025-02-28 2024-02-29 2023-02-28 2022-02-28 2021-02-28
Investments -0.01M 0.00M 0.00M 1.85M -0.01M
Change to liabilities - - 1.30M -1.35M -0.18M
Total cashflows from investing activities - - - 1.85M -0.01M
Net borrowings -0.38M 1.22M 0.70M -0.16M 0.84M
Total cash from financing activities 1.01M 2.43M 0.86M 1.13M 1.65M
Change to operating activities - - 0.08M -0.02M -0.05M
Net income -5.40M -4.31M -3.81M -8.49M -2.30M
Change in cash -0.14M 0.13M -0.01M -0.04M 0.07M
Begin period cash flow 0.16M 0.03M 0.03M 0.07M 0.00M
End period cash flow 0.02M 0.16M 0.03M 0.03M 0.07M
Total cash from operating activities -1.15M -2.29M -0.86M -3.00M -1.62M
Issuance of capital stock 1.39M 1.21M 0.15M 0.00M 0.90M
Depreciation 0.24M 0.62M 0.63M 0.77M 0.68M
Change to inventory -0.11M 0.01M 0.08M -0.04M -0.19M
Change to account receivables - - - 0.20M -0.14M
Other cashflows from financing activities - - - - -0.09M
Change to netincome - - 0.86M 5.93M 0.07M
Capital expenditures 0.01M 0.00M 0.00M 0.04M 0.01M
Change in working capital 1.52M 0.49M 1.46M -1.21M -0.07M
Stock based compensation 1.42M 0.16M 0.71M 1.70M 0.00M
Other non cash items 1.08M 0.19M 0.12M 0.01M -
Free cash flow -1.15M -2.29M -0.86M -3.04M -1.63M

Peer Comparison*

Sector: Healthcare Industry: Biotechnology

Stock Name
Change
(CAD)
Price
(CAD)
Trailing
PE (x)
Forward
PE (x)
Price Sales
TTM (x)
Price to Book Value (x)
Enterprise Value
to Revenue (x)
Enterprise Value
to EBITDA (x)
DOSE
Rapid Dose Therapeutics Corp		 0.01
16.67%		 0.10 - - 5.09 29.86 7.23 -1.21
DRUG
Bright Minds Biosciences Inc		 0.10
0.27%		 37.08 - - - 13.50 - -0.10
METX
ME Therapeutics Holdings Inc.		 -
-%		 1.10 - - - 72.00 - -
TELI
Telescope Innovations Corp.		 0.01
3.12%		 0.33 - - 4.32 6.45 4.32 -1.62
DTC
Defence Therapeutics Inc		 -0.02
5.88%		 0.32 - - - 89.80 - -9.99

Profile*

Rapid Dose Therapeutics Corp

Rapid Dose Therapeutics Corp., a life sciences company, provides drug delivery technologies in Canada. The company offers QuickStrip/PharmaStrip, an oral fast-dissolving drug delivery system to rapidly release into the blood stream a list of pharmaceuticals, emulsified oils, and over-the-counter medicines; QuickStrip Energy to deliver energizing caffeine; QuickStrip B12 to deliver vitamin B12 in the system; and QuickStrip sleep that delivers melatonin in the system, as well as dental products. It also engages in the research, production, provision, and distribution of technical services for the delivery of oral thin film strips that consists of active ingredients. In addition, the company sells health and wellness products, such as nutraceuticals and infused soaps; and white label manufacturing, including oral thin film strips containing active ingredients under cannabis licensing, as well as provides consulting services for the application of active ingredients. Rapid Dose Therapeutics Corp. is headquartered in Burlington, Canada.

1121 Walker's Line, Burlington, ON, Canada, L7N 2G4

416 477 1052

https://rapid-dose.com

Name Title Year Born
Mr. Mark Andrew Upsdell Founder, President, CEO & Director NA
Mr. Douglas Alan Hyland C.A., CPA Chief Financial Officer NA
Mr. Jason Lewis Senior VP of Business Development & Director NA
Paula MacBeth Director of Operations NA
Mr. Donald Alexander-R. Sheldon B.A.Sc., L.L.B., M.A.Sc., P.Eng. Legal Counsel 1947
Nissrine Ghannoum Director of Marketing & Communications NA
Rishi Kapadia Controller NA
Jorge Estepa Assistant Corporate Secretary NA

Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.

Kalkine

3 Mining Stock
Ideas Report

Download a free report with stock ideas and industry insights for general information.

Download Free Report Now → sector image

Top Stocks by Market Cap*

ORE
CAD 2.77
+8.86%
APM
CAD 4.95
+8.08%
NUAG
CAD 7.37
+8.06%
BZ
CAD 4.03
+8.04%
AYA
CAD 34.85
+7.96%
HUT
CAD 73.56
-17.26%
PHX
CAD 11.13
-12.22%
IVN
CAD 7.93
-10.70%
EFN
CAD 20.09
-10.39%
OBE
CAD 13.62
-6.71%

Equity Sectors*

  • Basic Materials

    +3.73%

  • Communication Services

    +1.16%

  • Consumer Cyclical

    +1.12%

  • Consumer Defensive

    +0.14%

  • Energy

    -1.87%

  • Financial Services

    +1.53%

  • Healthcare

    +1.50%

  • Industrials

    +0.03%

  • Real Estate

    +0.71%

  • Technology

    +0.40%

  • Utilities

    +0.35%

Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.

Support

Hi! How can we help you today?

Loading…